t-vec

Showing 3 posts of 3 posts found.

Imlygic

European approval for Amgen cancer drug Imlygic

December 18, 2015
Sales and Marketing Amgen, European Commission, Imlygic, melanoma, skin cancer, t-vec, talimogene laherparepvec

The European Commission has approved the use of Amgen’s Imlygic for adults with advanced melanoma, making it the first drug …

amgen

Amgen cold sore virus drug shows ‘significant’ cancer benefit

May 27, 2015
Research and Development, Sales and Marketing Amgen, Cancer, cold sore, t-vec

Amgen is pinning its hopes on investigational viral treatment T-VEC following promising results from a ‘landmark’ skin cancer study. People …

Amgen image

Amgen melanoma vaccine shrinks tumours

March 17, 2014
Research and Development, Sales and Marketing Amgen, Cancer, Yervoy, melanoma, t-vec

Amgen’s investigational cancer vaccine T-vec has managed to shrink the size of advanced melanoma tumours in a late-stage trial. The …

Latest content